Journal of Agricultural and Food Chemistry,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 24, 2025
Capsaicin
(CAP),
the
active
component
of
chili
peppers,
exerts
a
range
health
benefits,
including
anti-inflammatory,
antitumor,
obesity-prevention,
metabolic
control,
and
biological
rhythm-modulating
effects,
primarily
through
activation
transient
receptor
potential
vanilloid
1
(TRPV1)
receptor.
The
research
explores
role
TRPV1
its
interaction
with
hepatic
circadian
clock
regulation
in
modulating
lipid
metabolism
liver
health.
effect
CAP
on
mechanism
was
examined
HepG2
cells
high-fat,
high-sugar
diet
(HFFD)-induced
obese
mice.
In
vitro,
(50
μM)
decreased
droplet
overaccumulation
(from
152.8
±
2.30
to
110.13
3.91%),
enhanced
mitochondrial
function
57.94
1.93
86.74
1.83%),
alleviated
desynchrony
Trpv1-dependent
cells.
vivo,
(5
mg/kg)
reduced
body
weight
gain
50.61
3.77
38.36
2.04%),
restored
rhythm,
modulated
expression
lipid-related
genes
involvement
This
study
highlighted
attenuate
Reverbα-mediated
dysfunction
mechanism,
revealing
complex
interplay
between
metabolism.
Frontiers in Oncology,
Journal Year:
2022,
Volume and Issue:
12
Published: July 14, 2022
Sterol
regulatory
element
binding
protein-1
(SREBP-1),
a
transcription
factor
with
basic
helix–loop–helix
leucine
zipper,
has
two
isoforms,
SREBP-1a
and
SREBP-1c,
derived
from
the
same
gene
for
regulating
genes
of
lipogenesis,
including
acetyl-CoA
carboxylase,
fatty
acid
synthase,
stearoyl-CoA
desaturase.
Importantly,
SREBP-1
participates
in
metabolic
reprogramming
various
cancers
been
biomarker
prognosis
or
drug
efficacy
patients
cancer.
In
this
review,
we
first
introduced
structure,
activation,
key
upstream
signaling
pathway
SREBP-1.
Then,
potential
targets
molecular
mechanisms
SREBP-1-regulated
lipogenesis
types
cancer,
such
as
colorectal,
prostate,
breast,
hepatocellular
were
summarized.
We
also
discussed
therapies
targeting
by
small
molecules,
natural
products,
extracts
herbs
against
tumor
progression.
This
review
could
provide
new
insights
understanding
advanced
findings
about
SREBP-1-mediated
cancer
its
target
therapeutics.
Journal of Translational Medicine,
Journal Year:
2023,
Volume and Issue:
21(1)
Published: May 4, 2023
Abstract
Alcoholism
is
a
widespread
and
damaging
behaviour
of
people
throughout
the
world.
Long-term
alcohol
consumption
has
resulted
in
alcoholic
liver
disease
(ALD)
being
leading
cause
chronic
disease.
Many
metabolic
enzymes,
including
dehydrogenases
such
as
ADH,
CYP2E1,
CATacetaldehyde
ALDHsand
nonoxidative
metabolizing
enzymes
SULT,
UGT,
FAEES,
are
involved
metabolism
ethanol,
main
component
beverages.
Ethanol
changes
functional
or
expression
profiles
various
regulatory
factors,
kinases,
transcription
microRNAs.
Therefore,
underlying
mechanisms
ALD
complex,
involving
inflammation,
mitochondrial
damage,
endoplasmic
reticulum
stress,
nitrification,
oxidative
stress.
Moreover,
recent
evidence
demonstrated
that
gut-liver
axis
plays
critical
role
pathogenesis.
For
example,
ethanol
damages
intestinal
barrier,
resulting
release
endotoxins
alterations
flora
content
bile
acid
metabolism.
However,
therapies
show
low
effectiveness.
this
review
summarizes
pathways
highly
influential
pathogenic
factors
pathology
with
aim
new
therapeutic
insights.
Signal Transduction and Targeted Therapy,
Journal Year:
2024,
Volume and Issue:
9(1)
Published: April 4, 2024
Abstract
NEDD8
(Neural
precursor
cell
expressed
developmentally
downregulated
protein
8)
is
an
ubiquitin-like
that
covalently
attached
to
a
lysine
residue
of
substrate
through
process
known
as
neddylation,
catalyzed
by
the
enzyme
cascade,
namely
activating
(E1),
conjugating
(E2),
and
ligase
(E3).
The
substrates
neddylation
are
categorized
into
cullins
non-cullin
proteins.
Neddylation
activates
CRLs
(cullin
RING
ligases),
largest
family
E3
ligases,
whereas
alters
their
stability
activity,
well
subcellular
localization.
Significantly,
pathway
and/or
many
abnormally
activated
or
over-expressed
in
various
human
diseases,
such
metabolic
disorders,
liver
dysfunction,
neurodegenerative
cancers,
among
others.
Thus,
targeting
becomes
attractive
strategy
for
treatment
these
diseases.
In
this
review,
we
first
provide
general
introduction
on
its
biochemical
regulation,
crystal
structures
enzymes
complex
with
cullin
substrates;
then
discuss
how
governs
key
biological
processes
via
modification
substrates.
We
further
review
literature
data
dysregulated
several
particularly
cancer,
followed
outline
current
efforts
discovery
small
molecule
inhibitors
promising
therapeutic
approach.
Finally,
few
perspectives
were
proposed
extensive
future
investigations.
International Journal of Molecular Sciences,
Journal Year:
2025,
Volume and Issue:
26(2), P. 788 - 788
Published: Jan. 18, 2025
Diets
rich
in
carbohydrate
and
saturated
fat
contents,
when
combined
with
a
sedentary
lifestyle,
contribute
to
the
development
of
obesity
metabolic
syndrome
(MetS),
which
subsequently
increase
palmitic
acid
(PA)
levels.
At
high
concentrations,
PA
induces
lipotoxicity
through
several
mechanisms
involving
endoplasmic
reticulum
(ER)
stress,
mitochondrial
dysfunction,
inflammation
cell
death.
Nevertheless,
there
are
endogenous
strategies
mitigate
PA-induced
its
unsaturation
elongation
channeling
storage
lipid
droplets
(LDs),
plays
crucial
role
sequestering
oxidized
lipids,
thereby
reducing
oxidative
damage
membranes.
While
extended
exposure
promotes
reactive
oxygen
species
(ROS)
generation
leading
damage,
acute
ß-cells
increases
glucose-stimulated
insulin
secretion
(GSIS),
activation
free
fatty
receptors
(FFARs).
Subsequently,
FFARs
by
exogenous
agonists
has
been
suggested
as
potential
therapeutic
strategy
prevent
ß
cells.
Moreover,
some
acids,
including
oleic
acid,
can
counteract
negative
impact
on
cellular
health,
suggesting
complex
interaction
between
different
dietary
fats
outcomes.
Therefore,
challenge
is
peroxidation
unsaturated
acids
utilization
natural
antioxidants.
This
complexity
indicates
necessity
for
further
research
into
function
diverse
pathological
conditions
find
main
target
against
lipotoxicity.
The
aim
this
review
is,
therefore,
examine
recent
data
regarding
mechanism
underlying
order
identify
that
promote
protection
lipotoxicity,
dysfunction
apoptosis
MetS
obesity.
Frontiers in Endocrinology,
Journal Year:
2023,
Volume and Issue:
14
Published: Oct. 23, 2023
Forkhead
box
O
(FoxO)
proteins
are
transcription
factors
that
mediate
many
aspects
of
physiology
and
thus
have
been
targeted
as
therapeutics
for
several
diseases
including
metabolic
disorders
such
type
2
diabetes
mellitus
(T2D).
The
role
FoxO1
in
metabolism
has
well
studied,
but
recently
FoxO1’s
potential
prevention
therapy
debated.
For
example,
studies
shown
increased
activity
certain
tissue
types
contributes
to
T2D
pathology,
symptoms,
comorbidities,
yet
other
elevated
reported
alleviate
symptoms
associated
with
diabetes.
Furthermore,
opposite
effects
active
the
same
type.
liver,
by
increasing
hepatic
glucose
production.
However,
either
increase
or
decrease
lipogenesis
adipogenesis
white
adipose
tissue.
In
skeletal
muscle,
reduces
uptake
oxidation,
promotes
lipid
increases
muscle
atrophy.
While
show
lowers
pancreatic
insulin
production
secretion,
others
opposite,
especially
response
oxidative
stress
inflammation.
Elevated
hypothalamus
risk
developing
T2D.
may
mitigate
Alzheimer’s
disease,
a
neurodegenerative
disease
strongly
Conversely,
accumulating
evidence
implicates
Parkinson’s
pathogenesis.
Here
we
review
actions
conditions
tissues
abundantly
express
highlight
some
current
targeting
treatment.
Journal of the Science of Food and Agriculture,
Journal Year:
2024,
Volume and Issue:
104(10), P. 5882 - 5895
Published: Feb. 26, 2024
Yellow
leaf
green
tea
(YLGT)
is
a
new
variety
of
Camellia
sinensis
(L.)
O.
Ktze,
which
has
yellow
leaves
and
the
unique
qualities
'three
through
three
yellow'.
The
present
study
aimed
to
investigate
anti-obesity
effect
YLGT
in
mice
fed
high-fat
diet
(HFD)
explore
potential
mechanisms
by
regulating
AMPK/ACC/SREBP1c
signaling
pathways
gut
microbiota.
Annual Review of Nutrition,
Journal Year:
2022,
Volume and Issue:
42(1), P. 91 - 113
Published: May 19, 2022
Nonalcoholic
fatty
liver
disease
(NAFLD),
a
spectrum
of
metabolic
associated
with
obesity,
ranges
from
relatively
benign
hepatic
steatosis
to
nonalcoholic
steatohepatitis
(NASH).
The
latter
is
characterized
by
persistent
injury,
inflammation,
and
fibrosis,
which
collectively
increase
the
risk
for
end-stage
diseases
such
as
cirrhosis
hepatocellular
carcinoma.
Recent
work
has
shed
new
light
on
pathophysiology
NAFLD/NASH,
particularly
role
genetic,
epigenetic,
dietary
factors
dysfunctions
in
other
tissues
driving
excess
fat
accumulation
injury.
In
parallel,
single-cell
RNA
sequencing
studies
have
revealed
unprecedented
details
molecular
nature
cell
heterogeneity,
intrahepatic
cross
talk,
disease-associated
reprogramming
immune
stromal
vascular
microenvironment.
This
review
covers
recent
advances
these
areas,
emerging
concepts
NASH
pathogenesis,
potential
therapeutic
opportunities.